J. Brandes, D. Kudrow, R. Cady, P. Tiseo, W. Sun et al., Eletriptan in the early treatment of acute migraine: Influence of pain intensity and time of dosing Sumatriptan-naproxen for acute treatment of migraine: a randomized trial Short-term frovatriptan for the prevention of difficultto-treat menstruel migraine attacks, Headache Cephalalgia JAMA Brandes JL Cephalalgia, vol.44, issue.29, pp.581-586, 2004.

S. Bulut, M. Berilgen, A. Baran, A. Tekatas, M. Atmaca et al., Venlafaxine versus amitriptyline in the prophylactic treatment of migraine: randomized, double-blind, crossover study, Clinical Neurology and Neurosurgery, vol.107, issue.1, pp.44-48, 2004.
DOI : 10.1016/j.clineuro.2004.03.004

C. Bushnell, M. Jamison, A. James, R. Cady, A. Elkind et al., Migraines during pregnancy linked to stroke and vascular diseases: US population based case?control study Randomized, placebocontrolled comparison of early use of frovatriptan in a migraine attack versus dosing after the headache has become moderate or severe, Br Med J Curr Med Res Opin, vol.338, issue.20, pp.664-231465, 2004.

R. Cady, V. Martin, A. Mauskop, A. Rodgers, C. Hustad et al., Efficacy of rizatriptan 10 mg administered early in a migraine attack Canadian Headache Society Prophylactic Guidelines Development Group (2012) Canadian headache society guideline for migraine prophylaxis, Headache Can J Neurol Sci, vol.46, issue.392, pp.914-924, 2006.

J. Carpay, J. Schoenen, F. Ahmad, F. Kinrade, and D. Boswell, Efficacy and tolerability of sumatriptan tablets in a fast-disintegrating, rapid-release formulation for the acute treatment of migraine: Results of a multicenter, randomized, placebo-controlled study, Clinical Therapeutics, vol.26, issue.2, pp.214-223, 2004.
DOI : 10.1016/S0149-2918(04)90020-3

Y. Cete, D. B. Ertan, C. Ozdemir, C. Oktay, C. Charlesworth et al., A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department, Cephalalgia, vol.17, issue.3, pp.199-204, 2003.
DOI : 10.1111/j.1572-0241.2000.02179.x

I. Colman, M. Brown, G. Innes, E. Grafstein, T. Roberts et al., Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials, BMJ, vol.329, issue.7479, pp.1369-1373, 2004.
DOI : 10.1136/bmj.38281.595718.7C

D. Diego, E. Lanteri-minet, and M. , Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT), Cephalalgia, vol.58, issue.3, pp.184-190, 2005.
DOI : 10.1001/archinte.152.6.1273

V. Demarin, V. Vukovic, A. Lovrencic-huzjan, I. Lusi?, D. Janculjak et al., Evidence based guidelines for the treatment of primary headaches, 2008.

S. Diamond, M. Bigal, S. Silberstein, E. Loder, M. Reed et al., Pattems of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study, Acta Med Croatica Headache, vol.62, issue.47, pp.99-136, 2007.

H. Diener, G. Bussone, D. Liano, H. Eikermann, A. Englert et al., Placebocontrolled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks, Cephalalgia, vol.24, pp.947-954, 2004.

H. Diener, A. Eikermann, U. Gessner, H. Gübel, G. Haag et al., Efficacy of 1,000 mg Effervescent Acetylsalicylic Acid and Sumatriptan in Treating Associated Migraine Symptoms, European Neurology, vol.52, issue.1, pp.50-56, 2004.
DOI : 10.1159/000079544

H. Diener, A. Gendolla, I. Gebert, and M. Beneke, Almotriptan in Migraine Patients Who Respond Poorly to Oral Sumatriptan: A Double-Blind, Randomized Trial, Headache: The Journal of Head and Face Pain, vol.57, issue.7, pp.874-882, 2005.
DOI : 10.1046/j.1468-2982.2000.00091.x

H. Diener, V. Pfaffenrath, J. Schnitker, M. Friede, and H. Henneicke-von-zepelin, -Extract (MIG-99) in Migraine Prevention ??? A Randomized, Double-Blind, Multicentre, Placebo-Controlled Study, Cephalalgia, vol.55, issue.8604, pp.1031-1041, 2005.
DOI : 10.1111/j.0006-341X.1999.01286.x
URL : https://hal.archives-ouvertes.fr/hal-01282923

H. Diener, P. Montagna, G. Gacs, P. Lyczak, G. Schumann et al., Efficacy and Tolerability of Diclofenac Potassium Sachets in Migraine, Cephalalgia, vol.137, issue.5, pp.537-547, 2006.
DOI : 10.1046/j.1526-4610.2001.041007646.x

H. Diener, A. Gendolla, A. Feuersenger, S. Evers, A. Straube et al., Telmisartan in Migraine Prophylaxis: A Randomized, Placebo-Controlled Trial, Cephalalgia, vol.59, issue.3, pp.921-927, 2009.
DOI : 10.1016/S1474-4422(04)00824-5

D. Dodick and V. Papademetriou, Cardiovascular Safety of Triptans, Cephalalgia, vol.48, issue.7, pp.513-514, 2004.
DOI : 10.1046/j.1526-4610.2001.041007646.x

D. Dodick, J. Brandes, A. Elkind, N. Mathew, and L. Rodichok, Speed of Onset, Efficacy and Tolerability of Zolmitriptan Nasal Spray in the Acute Treatment of Migraine, CNS Drugs, vol.43, issue.11, pp.125-136, 2005.
DOI : 10.2165/00023210-200519020-00003

D. Dodick, F. Freitag, J. Banks, J. Saper, J. Xziang et al., Topiramate versus amitriptyline in migraine prevention: A 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs, 277 Investigator Group, pp.542-559, 2004.
DOI : 10.1016/j.clinthera.2009.03.020

G. Duru, J. Auray, A. Gaudin, J. Dartigues, P. Henry et al., Impact of Headache on Quality of Life in a General Population Survey in France (GRIM2000 Study), Headache: The Journal of Head and Face Pain, vol.56, issue.1, pp.571-580, 2004.
DOI : 10.1185/030079901753403207

O. Eftedal, S. Lydersen, G. Helde, L. White, A. Brubakk et al., A Randomized, Double Blind Study of the Prophylactic Effect of Hyperbaric Oxygen Therapy on Migraine, Cephalalgia, vol.71, issue.8, pp.639-644, 2004.
DOI : 10.1111/j.1468-2982.2004.00724.x

E. Hasnaoui, A. Vray, M. Richard, A. , N. Ouinekh et al., Assessing the Severity of Migraine: Development of the MIGSEV Scale, Headache: The Journal of Head and Face Pain, vol.19, issue.6, pp.628-635, 2003.
DOI : 10.1001/jama.284.20.2599

M. Etminan, B. Takkouche, F. Isoma, A. Samii, S. Evers et al., Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies EFNS guideline on the drug treatment of migraine -revised report of an EFNS task force, Br Med J Eur J Neurol, vol.330, issue.16, pp.63-48968, 2005.

F. Facchinetti, R. Nappi, A. Tirelli, F. Polatti, G. Nappi et al., Hormone supplementation differently affects migraine in postmenopausal women Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan Headache prevalence among adolescents -the German DMKG headache study, Headache Cephalalgia Cephalalgia, vol.42, issue.27, pp.924-929, 2002.

K. Foley, R. Cady, V. Martin, J. Adelman, M. Diamond et al., Treating Early Versus Treating Mild: Timing of Migraine Prescription Medications Among Patients With Diagnosed Migraine, Headache: The Journal of Head and Face Pain, vol.60, issue.5, pp.538-545, 2005.
DOI : 10.1046/j.1526-4610.2002.02053.x

F. Freitag, G. Finlayson, A. Rapoport, A. Elkind, M. Diamond et al., Effect of Pain Intensity and Time to Administration on Responsiveness to Almotriptan: Results from AXERT?? 12.5 mg Time Versus Intensity Migraine Study (AIMS), Headache: The Journal of Head and Face Pain, vol.41, issue.4, pp.519-530, 2007.
DOI : 10.1111/j.1526-4610.2007.00756.x

F. Freitag, T. Smith, N. Mathew, M. Rupnow, S. Greenberg et al., Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the aegis trial Comparative efficacy of eletriptan vs Naratriptan in the acute treatment of migraine, Headache Cephalalgia, vol.48, issue.23, pp.341-354869, 2003.

M. Gawel, J. Aschoff, A. May, and B. Charlesworth, Zolmitriptan 5 mg Nasal Spray: Efficacy and Onset of Action in the Acute Treatment of Migraine-Results From Phase 1 of the REALIZE Study, Headache: The Journal of Head and Face Pain, vol.23, issue.Suppl 7, pp.7-16, 2005.
DOI : 10.1111/j.1526-4610.2005.05004.x

G. Geraud, A. Compagnon, and A. Rossi, Zolmitriptan versus a Combination of Acetylsalicylic Acid and Metoclopramide in the Acute Oral Treatment of Migraine: A Double-Blind, Randomised, Three-Attack Study, European Neurology, vol.47, issue.2, pp.88-98, 2002.
DOI : 10.1159/000047959

L. Gerbaud, M. Navez, P. Couratier, M. Lejeune, D. Vernay et al., Validation of the combined SF36/MSQ0L test of evaluation of quality of life in migraine patients in France, Rev Neurol, vol.158, pp.719-727, 2002.

P. Goadsby, G. Zanchin, G. Geraud, N. De-klippel, S. Diaz-insa et al., Early vs. Non-Early Intervention in Acute Migraine ??? ???Act When Mild (AwM)???. A Double-Blind, Placebo-Controlled Trial of Almotriptan, Cephalalgia, vol.27, issue.4, pp.383-391, 2008.
DOI : 10.1111/j.1526-4610.2006.00466.x

P. Goadsby, J. Goldberg, and S. Silberstein, Migraine in pregnancy, BMJ, vol.336, issue.7659, pp.1502-1504, 2008.
DOI : 10.1136/bmj.39559.675891.AD

H. Gobel, A. Heinze, U. Niederberger, T. Witt, and V. Zumbroich, Efficacy of Phenazone in the Treatment of Acute Migraine Attacks: A Double-Blind, Placebo-Controlled, Randomized Study, Cephalalgia, vol.47, issue.3, pp.888-893, 2004.
DOI : 10.1111/j.1468-2982.2004.00764.x

J. Goldstein, S. Silberstein, J. Saper, A. Elkind, T. Smith et al., Acetaminophen, Aspirin, and Caffeine Versus Sumatriptan Succinate in the Early Treatment of Migraine: Results From the ASSET trial, Headache: The Journal of Head and Face Pain, vol.43, issue.3, pp.973-982, 2005.
DOI : 10.1016/S0149-2918(01)80006-0

L. Goldstein, C. Bushnell, R. Adams, L. Appel, L. Braun et al., Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research, Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research (2011) Guidelines for the primary prevention of stroke. A guideline for healthcare professionals from the American Heart AssociationAmerican Stroke Association, American Heart Association Stroke Stroke, vol.42, pp.517-584

F. Granella, G. Sances, G. Allais, R. Nappi, A. Tirelli et al., Characteristics of Menstrual and Nonmenstrual Attacks in Women with Menstrually Related Migraine Referred to Headache Centres, Cephalalgia, vol.43, issue.9, pp.707-716, 2004.
DOI : 10.1212/WNL.45.6.1076

P. Gupta, S. Singh, V. Goyal, G. Shukla, and M. Behari, Low-Dose Topiramate Versus Lamotrigine in Migraine Prophylaxis (The Lotolamp Study), Headache: The Journal of Head and Face Pain, vol.2, issue.7, pp.402-412, 2007.
DOI : 10.1111/j.1526-4610.2004.04198.x

M. Harris and B. Kaneshiro, An evidence-based approach to hormonal contraception and headaches The International Classification of Headache Disorders: 2nd revision, Contraception Headache Classification Subcommittee of the International headache Society Cephalalgia, vol.80, issue.24, pp.417-421, 2004.

P. Henry, J. Auray, A. Gaudin, J. Dartigues, G. Duru et al., Prevalence and clinical characteristics of migraine in France, Neurology, vol.59, issue.2, pp.232-237, 2001.
DOI : 10.1212/WNL.59.2.232

S. Jelinski, W. Becker, S. Christie, F. Ahmad, W. Pryse-phillips et al., Pain Free Efficacy of Sumatriptan in the Early Treatment of Migraine, The Canadian Journal of Neurological Sciences, vol.19, issue.01, pp.73-79, 2006.
DOI : 10.1056/NEJM199108013250504

B. Kallen and P. Lygner, Delivery Outcome in Women Who Used Drugs for Migraine During Pregnancy With Special Reference to Sumatriptan, Headache: The Journal of Head and Face Pain, vol.105, issue.1, pp.351-356, 2001.
DOI : 10.1007/s002280050664

N. Karli, N. Akis, M. Zarifoglu, S. Akgôz, E. Irgil et al., Headache prevalence in adolescents aged 12 to 17: a student-based epidemiological study in Bursa A double-blind randomized controlled trial of topiramate and amitriptyline either alone or in combination for the prevention of migraine, Headache Keskinbora K, Aydinli I Clin Neurol Neurosurg, vol.46, issue.110, pp.649-455, 2006.

J. Klapper, C. Lucas, O. Rosjo, and B. Charlesworth, Benefits of Treating Highly Disabled Migraine Patients with Zolmitriptan while Pain is Mild, Cephalalgia, vol.11, issue.11, pp.918-924, 2004.
DOI : 10.1016/S0149-2918(00)80083-1

A. Kolodny, A. Polis, W. Battisti, L. Johnson-pratt, and F. Skobieranda, Comparison of Rizatriptan 5 mg and 10 mg Tablets and Sumatriptan 25 mg and 50 mg Tablets, Cephalalgia, vol.38, issue.7, pp.540-546, 2004.
DOI : 10.1111/j.1468-2982.2004.00707.x

S. Landy, N. Savani, S. Shackelford, J. Loftus, and M. Jones, Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine, International Journal of Clinical Practice, vol.19, issue.Suppl. 24, pp.913-919, 2004.
DOI : 10.1111/j.1368-5031.2004.00295.x

M. Lantéri-minet, J. Auray, E. Hasnaoui, A. Dartigues, J. Duru et al., Prevalence and description of chronic daily headache in the general population in France Evaluation of the efficacy of intravenous acetaminophen in the treatment of acute migraine attacks: a double-blind, placebo-controlled parallel group multicenter study Octreotide is not effective in the acute treatment of migraine, Pain Pain Cephalalgia, vol.02, issue.25, pp.143-149, 2003.

M. Lima, N. Padula, L. Santos, L. Oliveira, S. Agapejev et al., Critical Analysis of the International Classification of Headache Disorders Diagnostic Criteria (ICHD I-1988) and (ICHD II-2004), for Migraine in Children and Adolescents, Cephalalgia, vol.179, issue.11, pp.1042-1047, 2005.
DOI : 10.1111/j.1468-2982.2005.00954.x

R. Lipton, H. Gobel, K. Einhaupl, K. Wilks, and A. Mauskop, Petasites hybridus root (butterbur) is an effective preventive treatment for migraine, Neurology, vol.63, issue.12, pp.2240-2244, 2004.
DOI : 10.1212/01.WNL.0000147290.68260.11

R. Lipton, J. Goldstein, J. Baggish, A. Yataco, J. Sorrentino et al., Aspirin Is Efficacious for the Treatment of Acute Migraine, Headache: The Journal of Head and Face Pain, vol.8, issue.7, pp.283-292, 2005.
DOI : 10.1046/j.1526-4610.2003.03042.x

R. Lipton, M. Bigal, M. Diamond, F. Freitag, M. Reed et al., Migraine prevalence, disease burden, and the need for preventive therapy, Neurology, vol.68, issue.5, pp.343-349
DOI : 10.1212/01.wnl.0000252808.97649.21

E. Loder, S. Silberstein, S. Abu-shakra, L. Mueller, and T. Smith, Efficacy and Tolerability of Oral Zolmitriptan in Menstrually Associated Migraine: A Randomized, Prospective, Parallel-Group, Double-blind, Placebo-Controlled Study, Headache: The Journal of Head and Face Pain, vol.59, issue.suppl 7, pp.120-130, 2004.
DOI : 10.1111/j.1526-4610.2004.04027.x

E. Loder, R. Burch, and P. Rizzoli, The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines, Headache: The Journal of Head and Face Pain, vol.344, issue.2, pp.930-945, 2012.
DOI : 10.1111/j.1526-4610.2012.02185.x

L. Macclellan, W. Giles, C. J. Wozniak, M. Stern, B. Mitchell et al., Probable Migraine With Visual Aura and Risk of Ischemic Stroke: The Stroke Prevention in Young Women Study, Stroke, vol.38, issue.9, pp.2438-2445, 2007.
DOI : 10.1161/STROKEAHA.107.488395

E. Macgregor, Menstrual migraine: a clinical review, Journal of Family Planning and Reproductive Health Care, vol.33, issue.1, pp.36-47, 2007.
DOI : 10.1783/147118907779399684

E. Macgregor, Migraine and use of combined hormonal contraceptives: a clinical review, Journal of Family Planning and Reproductive Health Care, vol.33, issue.3, pp.159-169, 2007.
DOI : 10.1783/147118907781004750

E. Macgregor, Migraine in pregnancy and lactation: a clinical review, Journal of Family Planning and Reproductive Health Care, vol.33, issue.2, pp.83-93, 2007.
DOI : 10.1783/147118907780254312

E. Macgregor, A. Dowson, and P. Davies, Mouth-Dispersible Aspirin in the Treatment of Migraine: A Placebo-Controlled Study, Headache: The Journal of Head and Face Pain, vol.37, issue.4, pp.249-255, 2002.
DOI : 10.1046/j.1468-2982.2000.00101.x

E. Macgregor, A. Frith, J. Ellis, L. Aspinall, and A. Hackshaw, Prevention of menstrual attacks of migraine: A double-blind placebo-controlled crossover study, Neurology, vol.67, issue.12, pp.2159-2163, 2006.
DOI : 10.1212/01.wnl.0000249114.52802.55

R. Machado, A. Pereira, G. Coelho, L. Neri, L. Martin et al., Epidemiological and clinical aspects of migraine in users of combined oral contraceptives, Contraception, vol.81, issue.3, pp.202-208, 2010.
DOI : 10.1016/j.contraception.2009.09.006

M. Maizels, A. Blumenfeld, and R. Burchette, A Combination of Riboflavin, Magnesium, and Feverfew for Migraine Prophylaxis: A Randomized Trial, Headache: The Journal of Head and Face Pain, vol.44, issue.2, pp.885-890, 2004.
DOI : 10.1046/j.1468-2982.2002.00396.x

L. Mannix, E. Loder, R. Nett, L. Mueller, A. Rodgers et al., Rizatriptan for the Acute Treatment of ICHD-II Proposed Menstrual Migraine: Two Prospective, Randomized, Placebo-Controlled, Double-Blind Studies, Cephalalgia, vol.25, issue.5, pp.414-421, 2007.
DOI : 10.1212/WNL.55.10.1517

V. Martin and M. Behbehani, Ovarian Hormones and Migraine Headache: Understanding Mechanisms and Pathogenesis-Part I, Headache: The Journal of Head and Face Pain, vol.53, issue.1, pp.3-23, 2006.
DOI : 10.1196/annals.1286.006

V. Martin and M. Behbehani, Ovarian Hormones and Migraine Headache: Understanding Mechanisms and Pathogenesis-Part 2, Headache: The Journal of Head and Face Pain, vol.22, issue.4, pp.365-386, 2006.
DOI : 10.1046/j.1468-2982.1995.015003237.x

N. Mathew, Early Intervention With Almotriptan Improves Sustained Pain-free Response in Acute Migraine, Headache: The Journal of Head and Face Pain, vol.43, issue.pt 8, pp.1075-1079, 2003.
DOI : 10.1046/j.1526-4610.2003.03208.x

N. Mathew, J. Schoenen, P. Winner, N. Muirhead, and C. Sikes, Comparative Efficacy of Eletriptan 40 mg Versus Sumatriptan 100 mg, Headache: The Journal of Head and Face Pain, vol.57, issue.3, pp.214-222, 2003.
DOI : 10.1001/archinte.159.8.813

N. Mathew, J. Kailasam, and L. Meadors, Early Treatment of Migraine With Rizatriptan: A Placebo-Controlled Study, Headache: The Journal of Head and Face Pain, vol.4, issue.7, pp.669-673, 2004.
DOI : 10.1097/00019052-200206000-00015

D. Mei, A. Capuano, C. Vollono, M. Evangelista, D. Ferraro et al., Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study, Neurological Sciences, vol.25, issue.5, pp.245-250, 2004.
DOI : 10.1007/s10072-004-0350-0

R. Milla-'n-guerrero, R. Isais-milla-'n, S. Barreto-vizcaino, L. Rivera-castaño, A. Garcia-solorzano et al., Subcutaneous histamine versus sodium valproate in migraine prophylaxis: a randomized, controlled, double-blind study, European Journal of Neurology, vol.58, issue.1, pp.1079-1084, 2007.
DOI : 10.1159/000089048

R. Nappi, A. Cagnacci, F. Granella, F. Piccinini, F. Polatti et al., Course of primary headaches during hormone replacement therapy, Maturitas, vol.38, issue.2, pp.157-163, 2001.
DOI : 10.1016/S0378-5122(00)00215-2

L. Newman, L. Mannix, S. Landy, S. Silberstein, R. Lipton et al., Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study Maternal characteristics and migraine pharmacotherapy during pregnancy: cross-sectional analysis of data from a large cohort study, Headache Cephalalgia, vol.41, issue.29, pp.248-2561267, 2001.

J. Olesen, H. Diener, J. Schoenen, and J. Hettiarachchi, No effect of eletriptan administration during the aura phase of migraine, European Journal of Neurology, vol.310, issue.2, pp.671-677, 2004.
DOI : 10.1056/NEJM199412223312505

S. Ozyalcin, G. Talu, E. Kiziltan, B. Yucel, M. Ertas et al., The Efficacy and Safety of Venlafaxine in the Prophylaxis of Migraine, Headache: The Journal of Head and Face Pain, vol.7, issue.suppl 2, pp.144-152, 2005.
DOI : 10.1111/j.1526-4610.2005.05029.x

J. Pascual and X. Cabarrocas, Within-Patient Early Versus Delayed Treatment of Migraine Attacks With Almotriptan: The Sooner the Better, Headache: The Journal of Head and Face Pain, vol.38, issue.1, pp.28-31, 2002.
DOI : 10.1016/S0149-2918(01)80011-4

D. Patrick, M. Martin, D. Bushnell, and J. Pesa, Measuring satisfaction with migraine treatment: Expectations, importance, outcomes, and global ratings, Clinical Therapeutics, vol.25, issue.11, 2003.
DOI : 10.1016/S0149-2918(03)80345-4

V. Pfaffenrath, H. Diener, M. Fischer, M. Friede, H. Henneicke-von-zepelin et al., The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis -a double blind, multicentre, randomized placebo controlled dose response study Quality of life in childhood migraines: clinical impact and comparison to other chronic illnesses Quality of life in paediatric migraine: characterization of age-related effects using PedsQL 4.0 Economic impact of migraine and other episodic headaches in, Clin Ther Cephalalgia Pediatrics Cephalalgia, vol.251, issue.24, pp.2920-2935, 2002.

F. Pradalier, A. Lantéri-minet, M. Géraud, G. Allain, H. Lucas et al., The PROMISE Study: PROphylaxis of MIgraine with SEglor?? (Dihydroergotamine Mesilate) in French Primary Care, data from the GRIM2000 study, pp.985-999, 2004.
DOI : 10.2165/00023210-200418150-00009

T. Pringsheim, W. Davenport, D. Dodick, K. Ravishankar, A. Chakravarty et al., Acute treatment and prevention of menstrually related migraine headache Guidelines on the diagnosis and the current management of headache and related disorders, Neurology Ann Indian Acad Neurol, vol.70, issue.14, pp.1555-1563, 2008.

P. Sandor, D. Clemente, L. Coppola, G. Saenger, U. Fumal et al., Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial, Neurology, vol.64, issue.4, pp.713-715, 2005.
DOI : 10.1212/01.WNL.0000151975.03598.ED

G. Sandrini, R. Cerbo, D. Bene, E. Ferrari, A. Genco et al., Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, mu, International Journal of Clinical Practice, vol.60, issue.Suppl. 7, 2007.
DOI : 10.1111/j.1742-1241.2007.01458.x

K. Saunders, K. Merikangas, N. Low, V. Korff, M. Kessler et al., Impact of comorbidity on headache-related disability, Neurology, vol.70, issue.7, pp.538-547, 2008.
DOI : 10.1212/01.wnl.0000297192.84581.21

A. Scher, R. Lipton, W. Stewart, M. M. Bigal, P. Rist et al., Patterns of medication use by chronic and episodic headache sufferers in the general population: Results from the frequent headache epidemiology study, Cephalalgia, vol.67, issue.1, pp.321-328, 2006.
DOI : 10.1136/bmj.296.6618.313

F. Sheftell, R. Ryan, and V. Pitman, Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute Migraine: A Multicenter, Double-Blind, Placebo-Controlled Study Conducted in the United States, Headache: The Journal of Head and Face Pain, vol.20, issue.3, pp.202-213, 2003.
DOI : 10.1046/j.1526-4610.2001.01139.x

F. Sheftell, C. Dahlof, J. Brandes, R. Agosti, M. Jones et al., Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets, Clinical Therapeutics, vol.27, issue.4, pp.407-417, 2005.
DOI : 10.1016/j.clinthera.2005.04.003

S. Silberstein, S. Hurtchinson, S. Silberstein, W. Young, J. Mendizabal et al., Diagnosis and treatment of the menstrual migraine patient Acute migraine treatment with droperidol: a randomized, double-blind, placebocontrolled trial, Headache Alam AS Neurology, vol.48, issue.60, pp.115-123, 2003.

S. Silberstein, S. Tepper, J. Brandes, M. Diamond, J. Goldstein et al., Randomized, placebocontrolled trial of rofecoxib in the acute treatment of migraine, Neurology, vol.62, pp.15520-1557, 2004.

S. Silberstein, A. Elkind, C. Schreiber, C. Keywood, S. Silberstein et al., A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine Topiramate in migraine prevention: results of a large controlled trial Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebocontrolled trial Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with, 001 Study Group, pp.261-269, 2004.

S. Silberstein, E. Loder, S. Diamond, M. Reed, M. Bigal et al., Probable Migraine in the United States: Results Of The American Migraine Prevalence and Prevention (AMPP) Study, Cephalalgia, vol.63, issue.3, pp.220-234, 2007.
DOI : 10.1212/WNL.59.2.232

S. Silberstein, J. Saper, F. Berenson, M. Somogyi, M. Mc-cague et al., Oxcarbazepine in migraine headache: A double-blind, randomized, placebo-controlled study, Neurology, vol.70, issue.7, pp.548-555, 2008.
DOI : 10.1212/01.wnl.0000297551.27191.70

S. Silberstein, S. Holland, F. Freitag, D. Dodick, C. Argoff et al., Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Table 1, Neurology, vol.78, issue.17, pp.1337-1345, 2012.
DOI : 10.1212/WNL.0b013e3182535d20

T. Smith, A. Sunshine, S. Stark, D. Littlefield, S. Spruill et al., Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine, Headache: The Journal of Head and Face Pain, vol.6, issue.4, pp.983-991, 2005.
DOI : 10.1016/S0149-2918(01)80006-0

T. Steiner, H. Diener, E. Macgregor, J. Schoenen, N. Muirheads et al., Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine, Cephalalgia, vol.35, issue.10, pp.942-952, 2003.
DOI : 10.1046/j.1468-2982.2001.00169.x

W. Stewart and R. Lipton, Need for Care and Perceptions of MIDAS among Headache Sufferers Study, CNS Drugs, vol.30, issue.Supplement 1, pp.5-11, 2002.
DOI : 10.2165/00023210-200216001-00002

W. Stewart, R. Lipton, and K. Kolodner, Migraine Disability Assessment (MIDAS) Score: Relation to Headache Frequency, Pain Intensity, and Headache Symptoms, Headache: The Journal of Head and Face Pain, vol.42, issue.3, pp.258-265, 2003.
DOI : 10.1046/j.1526-4610.2001.01156.x

T. Hansen, P. Pascual, J. Ramadan, N. Dahlof, C. et al., International Headache Society Clinical Trials Subcommittee (2012) Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators Treatment Guideline Subcommittee of the Taiwan Headache Society (2008) Treatment guidelines for preventive treatment of migraine Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study, Cephalalgia Acta Neurol Taiwan Tuchman MM CNS Drugs, vol.32, issue.22, pp.6-38, 2008.

L. Vecsei, G. Gallacchi, I. Sagi, J. Semjen, J. Tajti et al., Diclofenac Epolamine is Effective in The Treatment of Acute Migraine Attacks. A Randomized, Crossover, Double Blind, Placebo-Controlled, Clinical Study, Cephalalgia, vol.18, issue.1, pp.29-34, 2007.
DOI : 10.1111/j.1468-2982.2007.01236.x

. Allergan, S. Almirall, A. Pharmaceuticals, G. Inc, E. Grunenthal et al., DV declares conflicts of interest with: Allergan

A. Allergan, A. Pharmaceuticals, G. Boehringer, . Inc, . Grunenthal et al., AD declares conflicts of interest with

. Bougouin-kuhn, M. Gp-), and . Chauvin, Association Francophone pour Vaincre les Douleurs Christelle Creac'h (neurologist) Emmanuelle De Diego (GP), Faycal Derouiche (neurologist), Renato Colamarino (neurologist), Philippe Cornet (GP) Valérie Domigo (neurologist), Virginie Dousset (neurologist) Colette Goujon (neurologist), Saad Kassnasrallah (neurologist), Jean-Louis Lajoie (GP-geriatrician), Dominique Latinville (neurologist)

P. Melard, Mirela Muresan (neurologist) Joclyne Paderi (AFVD) Virginie Piano (GP), Lok Rambaud (neurologist), Eric Salvat (GP), Alain Serrie (anaesthetist)